MyAverix Finance
HK · Healthcare
Everest Medicines Ltd (1952)
Biotechnology
Everest Medicines Ltd (1952) is listed on HK in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported market cap is $11.19B, P/E ratio is 18.00, net margin is -17.5%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 1952
Everest Medicines Ltd (1952) — FAQ
What is Everest Medicines Ltd's market cap?
Everest Medicines Ltd (1952) has a reported market cap of $11.19B (data as of 2026-05-21).
What is 1952's P/E ratio?
The price-to-earnings (P/E) ratio for Everest Medicines Ltd (1952) is 18.00 (data as of 2026-05-21).
Does Everest Medicines Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Everest Medicines Ltd (1952). Check the MyAverix Finance app for the latest dividend data.
What sector is Everest Medicines Ltd in?
Everest Medicines Ltd (1952) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 1952 listed on?
1952 is listed on HK.
What is Everest Medicines Ltd's net margin?
Everest Medicines Ltd (1952) reports a net margin of -17.5% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.